Brentuximab Vedotin with chemotherapy for stage III or IV Hodgkin’s Lymphoma

Connors, J M; Jurczak, W; Straus, D J; Ansell, S M; Kim, W S; Gallamini, A; Younes, A; Alekseev, S; Illès, A; Picardi, M; Lech-Maranda, E; Oki, Y; Feldman, T; Smolewski, P; Savage, K J; Bartlett, N L; Walewski, J; Chen, R; Ramchendren, R; Zinzani, P L; Cunningham, D; Rosta, A; Josephson, N C; Song, E; Sachs, J; Liu, R; Jolin, H A; Huebner, D; Radford, J; Santoro, A (member of ECHELON-1 Study)